天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2013年
11期
1063-1066
,共4页
陈闽荔%杜纪兵%刘寅%高静%崔让庄%陈树涛%丛洪良
陳閩荔%杜紀兵%劉寅%高靜%崔讓莊%陳樹濤%叢洪良
진민려%두기병%류인%고정%최양장%진수도%총홍량
基质金属蛋白酶3%多态现象,遗传%血管成形术,经腔,经皮冠状动脉%冠状动脉再狭窄
基質金屬蛋白酶3%多態現象,遺傳%血管成形術,經腔,經皮冠狀動脈%冠狀動脈再狹窄
기질금속단백매3%다태현상,유전%혈관성형술,경강,경피관상동맥%관상동맥재협착
matrix metalloproteinase 3%polymorphism,genetic%angioplasty,transluminal,percutaneous coronary%coronary restenosis
目的:探讨基质金属蛋白酶-3(MMP-3)启动子区域5A/6A基因多态性是否参与了经皮冠状动脉介入治疗(PCI)术后再狭窄发生发展过程。方法入选行PCI治疗术后复查的冠状动脉造影患者437例。收集患者复查冠状动脉造影前、后临床资料及造影结果,并留取血标本进行血清MMP-3含量以及基因多态性分析。根据MMP-3基因表型不同,分为突变组(5A/5A+5A/6A,n=136)和野生组(6A/6A,n=301)。比较2组相关资料,分析基因多态性与再狭窄的关系。结果2组再狭窄率差异无统计学意义(42.2%vs 33.1%,P>0.05)。与突变组比较,野生组再狭窄程度[(56.28±11.10)%vs(36.00±10.17)%]较高(P<0.01);2组血清MMP-3含量[(13.38±3.00)μg/L vs(12.33±2.96)μg/L]差异无统计学意义(P>0.05)。携带6A等位基因患者再狭窄率要高于携带5A等位基因患者(P<0.05)。携带野生基因型是PCI术后再狭窄的危险因素。结论携带6A等位基因患者再狭窄风险性明显高于携带5A等位基因患者。
目的:探討基質金屬蛋白酶-3(MMP-3)啟動子區域5A/6A基因多態性是否參與瞭經皮冠狀動脈介入治療(PCI)術後再狹窄髮生髮展過程。方法入選行PCI治療術後複查的冠狀動脈造影患者437例。收集患者複查冠狀動脈造影前、後臨床資料及造影結果,併留取血標本進行血清MMP-3含量以及基因多態性分析。根據MMP-3基因錶型不同,分為突變組(5A/5A+5A/6A,n=136)和野生組(6A/6A,n=301)。比較2組相關資料,分析基因多態性與再狹窄的關繫。結果2組再狹窄率差異無統計學意義(42.2%vs 33.1%,P>0.05)。與突變組比較,野生組再狹窄程度[(56.28±11.10)%vs(36.00±10.17)%]較高(P<0.01);2組血清MMP-3含量[(13.38±3.00)μg/L vs(12.33±2.96)μg/L]差異無統計學意義(P>0.05)。攜帶6A等位基因患者再狹窄率要高于攜帶5A等位基因患者(P<0.05)。攜帶野生基因型是PCI術後再狹窄的危險因素。結論攜帶6A等位基因患者再狹窄風險性明顯高于攜帶5A等位基因患者。
목적:탐토기질금속단백매-3(MMP-3)계동자구역5A/6A기인다태성시부삼여료경피관상동맥개입치료(PCI)술후재협착발생발전과정。방법입선행PCI치료술후복사적관상동맥조영환자437례。수집환자복사관상동맥조영전、후림상자료급조영결과,병류취혈표본진행혈청MMP-3함량이급기인다태성분석。근거MMP-3기인표형불동,분위돌변조(5A/5A+5A/6A,n=136)화야생조(6A/6A,n=301)。비교2조상관자료,분석기인다태성여재협착적관계。결과2조재협착솔차이무통계학의의(42.2%vs 33.1%,P>0.05)。여돌변조비교,야생조재협착정도[(56.28±11.10)%vs(36.00±10.17)%]교고(P<0.01);2조혈청MMP-3함량[(13.38±3.00)μg/L vs(12.33±2.96)μg/L]차이무통계학의의(P>0.05)。휴대6A등위기인환자재협착솔요고우휴대5A등위기인환자(P<0.05)。휴대야생기인형시PCI술후재협착적위험인소。결론휴대6A등위기인환자재협착풍험성명현고우휴대5A등위기인환자。
Objective To investigate the relationship between matrix metalloproteinase-3 (MMP-3) gene promoter polymorphisms 5A/6A and the restenosis after percutaneous coronary intervention (PCI). Methods A total of 437 patients with PCI were selected in this study. Patients were divided into mutant genotype group (5A/5A+5A/6A, n=136) and wild genotype group (6A/6A, n=301) according to MMP-3 polymorphism. The angiography and clinic data were collected before and after coronary angiography in two groups of patients. The serum level MMP-3 and genotype analysis were compared be-tween two groups. Results There was no significant difference in the restenosis rate between two groups (42.2%vs 33.1%, P>0.05). The restenosis degree was significantly higher in wild genotype group than that in mutant genotype group (56.28%± 11.10%vs 36.00%±10.17%, P<0.01). There was no significant difference in the serum level of MMP-3 between two groups (13.38μg/L ± 3.00μg/L vs 12.33μg/L ± 2.96μg/L, P>0.05). There was a higher restenosis rate in patients carrying 6A al-lele than that of patients carrying 5A allele (P<0.05). Carrying wild genotypes are risk factors for restenosis after PCI. Con-clusion Patients carrying 6A allele have significantly higher risk of resteonsis than patients carrying 5A allele.